| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
|
N Engl J Med
|
2012
|
27.84
|
|
2
|
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.
|
Lancet
|
2010
|
16.90
|
|
3
|
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.
|
Lancet Infect Dis
|
2011
|
10.96
|
|
4
|
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.
|
Sci Transl Med
|
2011
|
5.21
|
|
5
|
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
|
J Infect Dis
|
2007
|
4.52
|
|
6
|
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
|
Lancet
|
2010
|
4.23
|
|
7
|
Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men.
|
Am J Epidemiol
|
2004
|
4.03
|
|
8
|
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial.
|
PLoS One
|
2008
|
3.94
|
|
9
|
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
|
PLoS One
|
2009
|
3.66
|
|
10
|
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.
|
AIDS
|
2011
|
3.61
|
|
11
|
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
|
PLoS One
|
2011
|
3.27
|
|
12
|
Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples.
|
J Infect Dis
|
2012
|
3.06
|
|
13
|
Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.
|
PLoS One
|
2008
|
3.05
|
|
14
|
HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men.
|
AIDS
|
2002
|
3.03
|
|
15
|
Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.
|
J Infect Dis
|
2008
|
2.77
|
|
16
|
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
|
PLoS Med
|
2011
|
2.76
|
|
17
|
Combination HIV prevention: significance, challenges, and opportunities.
|
Curr HIV/AIDS Rep
|
2011
|
2.72
|
|
18
|
HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru.
|
J Acquir Immune Defic Syndr
|
2007
|
2.71
|
|
19
|
Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation.
|
AIDS
|
2010
|
2.70
|
|
20
|
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.
|
PLoS One
|
2010
|
2.48
|
|
21
|
HIV incidence determination in the United States: a multiassay approach.
|
J Infect Dis
|
2012
|
2.47
|
|
22
|
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
|
PLoS Med
|
2013
|
2.44
|
|
23
|
Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
|
Clin Infect Dis
|
2006
|
2.43
|
|
24
|
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
|
J Acquir Immune Defic Syndr
|
2014
|
2.43
|
|
25
|
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
|
PLoS One
|
2011
|
2.36
|
|
26
|
Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion.
|
AIDS
|
2002
|
2.33
|
|
27
|
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.
|
J Virol
|
2004
|
2.33
|
|
28
|
Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries.
|
Sex Transm Dis
|
2010
|
2.23
|
|
29
|
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis.
|
Lancet Infect Dis
|
2013
|
2.18
|
|
30
|
Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?
|
AIDS
|
2010
|
2.17
|
|
31
|
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.
|
PLoS Med
|
2012
|
2.06
|
|
32
|
Motivations for participating in an HIV vaccine efficacy trial.
|
J Acquir Immune Defic Syndr
|
2005
|
2.04
|
|
33
|
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.
|
J Acquir Immune Defic Syndr
|
2010
|
2.01
|
|
34
|
High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa.
|
J Acquir Immune Defic Syndr
|
2013
|
1.97
|
|
35
|
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.
|
J Acquir Immune Defic Syndr
|
2005
|
1.87
|
|
36
|
HIV-1 prevention for HIV-1 serodiscordant couples.
|
Curr HIV/AIDS Rep
|
2012
|
1.83
|
|
37
|
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
|
Lancet HIV
|
2015
|
1.77
|
|
38
|
Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters.
|
J Infect Dis
|
2013
|
1.74
|
|
39
|
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
|
J Infect Dis
|
2006
|
1.62
|
|
40
|
Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions.
|
Sex Transm Infect
|
2010
|
1.60
|
|
41
|
A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships.
|
Sex Transm Dis
|
2010
|
1.57
|
|
42
|
An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.
|
J Acquir Immune Defic Syndr
|
2013
|
1.55
|
|
43
|
Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial.
|
AIDS
|
2009
|
1.54
|
|
44
|
Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
|
AIDS Res Hum Retroviruses
|
2012
|
1.50
|
|
45
|
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
|
PLoS One
|
2011
|
1.46
|
|
46
|
Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
|
J Acquir Immune Defic Syndr
|
2012
|
1.44
|
|
47
|
HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
|
AIDS
|
2009
|
1.43
|
|
48
|
A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya.
|
AIDS Care
|
2011
|
1.43
|
|
49
|
Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
|
J Infect Dis
|
2004
|
1.41
|
|
50
|
Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.
|
Sex Transm Dis
|
2012
|
1.41
|
|
51
|
Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
|
J Acquir Immune Defic Syndr
|
2014
|
1.40
|
|
52
|
Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples.
|
AIDS
|
2010
|
1.37
|
|
53
|
Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.
|
Annu Rev Med
|
2012
|
1.36
|
|
54
|
Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure.
|
PLoS One
|
2011
|
1.35
|
|
55
|
Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships.
|
J Acquir Immune Defic Syndr
|
2012
|
1.34
|
|
56
|
Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.
|
Curr HIV Res
|
2012
|
1.33
|
|
57
|
HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
|
J Acquir Immune Defic Syndr
|
2002
|
1.33
|
|
58
|
'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.
|
AIDS
|
2014
|
1.32
|
|
59
|
Male circumcision and HIV risks and benefits for women.
|
Lancet
|
2009
|
1.31
|
|
60
|
A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples.
|
AIDS
|
2011
|
1.26
|
|
61
|
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
|
PLoS One
|
2013
|
1.24
|
|
62
|
Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation.
|
PLoS One
|
2012
|
1.24
|
|
63
|
Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
|
Ann Intern Med
|
2014
|
1.24
|
|
64
|
Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships.
|
AIDS
|
2012
|
1.24
|
|
65
|
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
|
AIDS
|
2013
|
1.19
|
|
66
|
Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance.
|
J Acquir Immune Defic Syndr
|
2006
|
1.18
|
|
67
|
Oral antiretroviral chemoprophylaxis: current status.
|
Curr Opin HIV AIDS
|
2012
|
1.13
|
|
68
|
My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya.
|
AIDS Care
|
2014
|
1.12
|
|
69
|
Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
|
J Infect Dis
|
2006
|
1.12
|
|
70
|
Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience.
|
J Acquir Immune Defic Syndr
|
2014
|
1.11
|
|
71
|
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
|
J Infect Dis
|
2011
|
1.09
|
|
72
|
Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.
|
J Acquir Immune Defic Syndr
|
2014
|
1.09
|
|
73
|
Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
|
J Infect Dis
|
2010
|
1.09
|
|
74
|
Male circumcision and risk of HIV acquisition among MSM.
|
AIDS
|
2011
|
1.06
|
|
75
|
The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic.
|
Herpes
|
2005
|
1.05
|
|
76
|
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
|
J Infect Dis
|
2011
|
1.04
|
|
77
|
HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
|
J Immunol
|
2003
|
1.03
|
|
78
|
Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
|
Sex Transm Infect
|
2011
|
1.03
|
|
79
|
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
|
J Acquir Immune Defic Syndr
|
2016
|
1.02
|
|
80
|
Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.
|
Drugs
|
2007
|
1.02
|
|
81
|
Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.
|
AIDS Res Hum Retroviruses
|
2013
|
1.02
|
|
82
|
HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact.
|
J Infect Dis
|
2013
|
1.00
|
|
83
|
Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women.
|
AIDS Behav
|
2013
|
0.98
|
|
84
|
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.
|
J Acquir Immune Defic Syndr
|
2014
|
0.98
|
|
85
|
Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.
|
AIDS
|
2014
|
0.97
|
|
86
|
High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
|
J Acquir Immune Defic Syndr
|
2014
|
0.97
|
|
87
|
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
|
AIDS
|
2015
|
0.97
|
|
88
|
Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence.
|
AIDS Behav
|
2013
|
0.96
|
|
89
|
Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
|
AIDS
|
2014
|
0.96
|
|
90
|
Antiretroviral preexposure prophylaxis for HIV prevention.
|
N Engl J Med
|
2013
|
0.96
|
|
91
|
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.
|
J Clin Microbiol
|
2013
|
0.95
|
|
92
|
Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships.
|
J Acquir Immune Defic Syndr
|
2013
|
0.94
|
|
93
|
A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women.
|
J Acquir Immune Defic Syndr
|
2014
|
0.94
|
|
94
|
Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1.
|
J Infect Dis
|
2012
|
0.94
|
|
95
|
Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda.
|
AIDS Behav
|
2010
|
0.93
|
|
96
|
A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.
|
AIDS Behav
|
2011
|
0.93
|
|
97
|
Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.
|
J Infect Dis
|
2012
|
0.92
|
|
98
|
Hormonal contraceptive use and risk of HIV-1 disease progression.
|
AIDS
|
2013
|
0.92
|
|
99
|
HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.
|
AIDS
|
2014
|
0.91
|
|
100
|
Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans.
|
J Infect Dis
|
2013
|
0.91
|
|
101
|
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
|
J Infect Dis
|
2013
|
0.89
|
|
102
|
Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.
|
J Acquir Immune Defic Syndr
|
2008
|
0.89
|
|
103
|
Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda.
|
PLoS One
|
2011
|
0.88
|
|
104
|
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
|
J Clin Microbiol
|
2010
|
0.88
|
|
105
|
Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
|
J Virol
|
2006
|
0.86
|
|
106
|
New insights on interactions between HIV-1 and HSV-2.
|
Curr Infect Dis Rep
|
2009
|
0.86
|
|
107
|
Control of sexually transmitted infections for HIV prevention.
|
Lancet
|
2008
|
0.86
|
|
108
|
Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples.
|
AIDS Behav
|
2014
|
0.84
|
|
109
|
Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial.
|
BMC Infect Dis
|
2012
|
0.84
|
|
110
|
Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting.
|
AIDS Behav
|
2013
|
0.83
|
|
111
|
Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
|
J Infect Dis
|
2010
|
0.83
|
|
112
|
Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.
|
PLoS One
|
2012
|
0.82
|
|
113
|
Estimating Efficacy in a Randomized Trial With Product Nonadherence: Application of Multiple Methods to a Trial of Preexposure Prophylaxis for HIV Prevention.
|
Am J Epidemiol
|
2015
|
0.82
|
|
114
|
Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations.
|
Antimicrob Agents Chemother
|
2012
|
0.80
|
|
115
|
Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
|
J Med Virol
|
2011
|
0.80
|
|
116
|
Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa.
|
AIDS
|
2016
|
0.80
|
|
117
|
Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
|
J Acquir Immune Defic Syndr
|
2017
|
0.80
|
|
118
|
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.
|
J Acquir Immune Defic Syndr
|
2016
|
0.80
|
|
119
|
'If you are circumcised, you are the best': understandings and perceptions of voluntary medical male circumcision among men from KwaZulu-Natal, South Africa.
|
Cult Health Sex
|
2015
|
0.79
|
|
120
|
Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons.
|
BMC Res Notes
|
2011
|
0.79
|
|
121
|
Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation.
|
AIDS
|
2016
|
0.78
|
|
122
|
Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.
|
J Acquir Immune Defic Syndr
|
2016
|
0.78
|
|
123
|
Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.
|
J Acquir Immune Defic Syndr
|
2015
|
0.78
|
|
124
|
Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men.
|
AIDS
|
2014
|
0.76
|
|
125
|
Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
126
|
Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.
|
Sex Transm Dis
|
2016
|
0.75
|
|
127
|
Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans.
|
J Acquir Immune Defic Syndr
|
2014
|
0.75
|
|
128
|
Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships.
|
Sex Transm Dis
|
2017
|
0.75
|
|
129
|
Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
130
|
Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
131
|
Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
|
Sex Transm Dis
|
2016
|
0.75
|
|
132
|
The Effect of Oral Pre-Exposure Prophylaxis on the Progression of HIV-1 Seroconversion.
|
AIDS
|
2017
|
0.75
|
|
133
|
Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
134
|
Context matters: PrEP adherence is associated with sexual behavior among HIV serodiscordant couples in East Africa.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
135
|
Intimate partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|